We are live on ! Find out more
CLLS

Cellectis
CLLS

37 hedge funds and large institutions have $96.1M invested in Cellectis in 2016 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

16.05% more ownership

Funds ownership: 0% → 16.05% (+16%)

13% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 8

9% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 11

3% less funds holding

Funds holding: 38 → 37 (-1)

40% less capital invested

Capital invested by funds: $160M → $96.1M (-$63.8M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $766K

Holders
37
Holders Change
-1
Holders Change %
-2.63%
% of All Funds
0.93%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
10
Increased
9
Reduced
8
Closed
11
Calls
–
Puts
$766K
Net Calls
-$766K
Net Calls Change
-$760K

Top Buyers

Rank Fund Capital Flow
1
DA
DSC Advisors
Illinois
+$1.06M
2
ACA
Avoro Capital Advisors
New York
+$710K
3
VIA
Vident Investment Advisory
Georgia
+$319K
4
Lazard Asset Management
Lazard Asset Management
New York
+$282K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$272K

Top Sellers

Rank Fund Capital Flow
1
CAM
Cormorant Asset Management
Massachusetts
-$12M
2
PA
Perceptive Advisors
New York
-$4.32M
3
CCP
Clough Capital Partners
Massachusetts
-$3.69M
4
Millennium Management
Millennium Management
New York
-$2.06M
5
Deutsche Bank
Deutsche Bank
Germany
-$1.24M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$59.8M +$2.75K +149 +0%
O
2
OrbiMed
New York
$5.93M – – –
TCM
3
Tekla Capital Management
Massachusetts
$5.26M – – –
Lazard Asset Management
4
Lazard Asset Management
New York
$5.1M +$282K +15,285 +5%
Franklin Resources
5
Franklin Resources
California
$4.13M – – –
AG
6
Artal Group
Luxembourg
$2.54M – – –
A
7
Abingworth
United Kingdom
$1.69M – – –
ACA
8
Avoro Capital Advisors
New York
$1.65M +$710K +38,425 +65%
Millennium Management
9
Millennium Management
New York
$1.2M -$2.06M -111,332 -61%
Morgan Stanley
10
Morgan Stanley
New York
$1.19M +$96.8K +5,240 +8%
DA
11
DSC Advisors
Illinois
$975K +$1.06M +57,500 New
Hudson Bay Capital Management
12
Hudson Bay Capital Management
Connecticut
$943K – – –
GH
13
GAM Holding
Switzerland
$899K -$28.6K -1,550 -3%
BBA
14
Baker Bros. Advisors
New York
$848K – – –
UBS Group
15
UBS Group
Switzerland
$782K -$938K -50,766 -52%
VIA
16
Vident Investment Advisory
Georgia
$720K +$319K +17,244 +68%
Susquehanna International Group
17
Susquehanna International Group
Pennsylvania
$258K +$65.2K +3,528 +30%
Geode Capital Management
18
Geode Capital Management
Massachusetts
$249K +$272K +14,707 New
PMAM
19
Picton Mahoney Asset Management
Ontario, Canada
$247K +$113K +6,100 +72%
Citadel Advisors
20
Citadel Advisors
Florida
$221K -$316K -17,112 -57%
HighTower Advisors
21
HighTower Advisors
Illinois
$210K -$22.8K -1,235 -9%
EMG
22
Ellington Management Group
Connecticut
$210K +$229K +12,400 New
Fiera Capital (Canada)
23
Fiera Capital (Canada)
Quebec, Canada
$203K – – –
OMC
24
Old Mission Capital
Illinois
$186K +$202K +10,956 New
Bank of America
25
Bank of America
North Carolina
$179K -$106K -5,758 -35%
1
2

CLLS Hedge Fund Activity: Q4 2016 in Review

37 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Cellectis (CLLS) for Q4 2016, worth a combined $96.1M — down 40% from $160M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of CLLS and 10 opened new positions — a net loss of 1 holder — while 8 trimmed existing stakes and 9 added.

The largest buyer was DSC Advisors, opening a new position worth an estimated $1.06M. The largest seller was Cormorant Asset Management, exiting entirely with an estimated $12M sold.

  • 37 institutional investors held Cellectis (CLLS) as of Q4 2016, down from 38 in Q3 2016.
  • Funds reported $96.1M of Cellectis stock for Q4 2016, down 40% quarter-over-quarter.
  • 10 funds opened new Cellectis positions in Q4 2016 and 11 closed out, a net change of -1 holder.
  • The largest Cellectis buyer in Q4 2016 was DSC Advisors, an estimated $1.06M added.
  • The largest Cellectis seller in Q4 2016 was Cormorant Asset Management, an estimated $12M sold.

Based on aggregated 13F filings for Q4 2016.